KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Treasury Shares (2017 - 2025)

Novartis Ag (NVS) has disclosed Treasury Shares for 9 consecutive years, with $50.0 million as the latest value for Q4 2025.

  • Quarterly Treasury Shares fell 5.66% to $50.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $50.0 million through Dec 2025, down 5.66% year-over-year, with the annual reading at $50.0 million for FY2025, 5.66% down from the prior year.
  • Treasury Shares hit $50.0 million in Q4 2025 for Novartis Ag, down from $53.0 million in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $92.0 million in Q4 2022 to a low of $41.0 million in Q4 2023.
  • Historically, Treasury Shares has averaged $56.8 million across 5 years, with a median of $50.0 million in 2025.
  • Biggest five-year swings in Treasury Shares: soared 91.67% in 2022 and later crashed 55.43% in 2023.
  • Year by year, Treasury Shares stood at $48.0 million in 2021, then surged by 91.67% to $92.0 million in 2022, then plummeted by 55.43% to $41.0 million in 2023, then increased by 29.27% to $53.0 million in 2024, then decreased by 5.66% to $50.0 million in 2025.
  • Business Quant data shows Treasury Shares for NVS at $50.0 million in Q4 2025, $53.0 million in Q4 2024, and $41.0 million in Q4 2023.